Cytokinetics, Incorporated - Common Stock (NQ:CYTK)Price and VolumeDetailed Quote
Top NewsMore News
Performance
More NewsRead More
European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO
February 23, 2026
Via MarketMinute
Topics
Intellectual Property
From Grabar Law Office
Via GlobeNewswire
Via MarketMinute
From Grabar Law Office
Via GlobeNewswire
Via MarketMinute
From Grabar Law Office
Via GlobeNewswire
Via MarketMinute
From Grabar Law Office
Via GlobeNewswire
From Grabar Law Office
Via GlobeNewswire
Via The Motley Fool
Topics
Regulatory Compliance
Frequently Asked QuestionsIs Cytokinetics, Incorporated - Common Stock publicly traded?
Yes, Cytokinetics, Incorporated - Common Stock is publicly traded.
What exchange does Cytokinetics, Incorporated - Common Stock trade on?
Cytokinetics, Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cytokinetics, Incorporated - Common Stock?
The ticker symbol for Cytokinetics, Incorporated - Common Stock is CYTK on the Nasdaq Stock Market
What is the current price of Cytokinetics, Incorporated - Common Stock?
The current price of Cytokinetics, Incorporated - Common Stock is 60.00
When was Cytokinetics, Incorporated - Common Stock last traded?
The last trade of Cytokinetics, Incorporated - Common Stock was at 03/12/26 04:00 PM ET
What is the market capitalization of Cytokinetics, Incorporated - Common Stock?
The market capitalization of Cytokinetics, Incorporated - Common Stock is 5.74B
How many shares of Cytokinetics, Incorporated - Common Stock are outstanding?
Cytokinetics, Incorporated - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>